Medical - Devices
Compare Stocks
2 / 10Stock Comparison
QTRX vs NTRA
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
QTRX vs NTRA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Medical - Diagnostics & Research |
| Market Cap | $129M | $31.16B |
| Revenue (TTM) | $145M | $2.31B |
| Net Income (TTM) | $-104M | $-208M |
| Gross Margin | 44.1% | 64.8% |
| Operating Margin | -96.4% | -13.4% |
| Total Debt | $37M | $214M |
| Cash & Equiv. | $30M | $1.08B |
QTRX vs NTRA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Quanterix Corporati… (QTRX) | 100 | 10.0 | -90.0% |
| Natera, Inc. (NTRA) | 100 | 501.3 | +401.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: QTRX vs NTRA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
In this particular matchup, QTRX is outpaced on most metrics by others in the set.
NTRA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.26
- Rev growth 35.9%, EPS growth 0.7%, 3Y rev CAGR 41.1%
- 20.9% 10Y total return vs QTRX's -84.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.9% revenue growth vs QTRX's 2.6% | |
| Quality / Margins | -9.0% margin vs QTRX's -71.9% | |
| Stability / Safety | Beta 1.26 vs QTRX's 1.98, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +37.3% vs QTRX's -48.7% | |
| Efficiency (ROA) | -10.6% ROA vs QTRX's -26.0%, ROIC -36.1% vs -21.4% |
QTRX vs NTRA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
QTRX vs NTRA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NTRA leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NTRA is the larger business by revenue, generating $2.3B annually — 15.9x QTRX's $145M. NTRA is the more profitable business, keeping -9.0% of every revenue dollar as net income compared to QTRX's -71.9%. On growth, NTRA holds the edge at +39.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $145M | $2.3B |
| EBITDAEarnings before interest/tax | -$125M | -$310M |
| Net IncomeAfter-tax profit | -$104M | -$208M |
| Free Cash FlowCash after capex | -$83M | $97M |
| Gross MarginGross profit ÷ Revenue | +44.1% | +64.8% |
| Operating MarginEBIT ÷ Revenue | -96.4% | -13.4% |
| Net MarginNet income ÷ Revenue | -71.9% | -9.0% |
| FCF MarginFCF ÷ Revenue | -57.2% | +4.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.3% | +39.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +30.2% | +185.4% |
Valuation Metrics
QTRX leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $129M | $31.2B |
| Enterprise ValueMkt cap + debt − cash | $136M | $30.3B |
| Trailing P/EPrice ÷ TTM EPS | -1.10x | -144.62x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.93x | 13.51x |
| Price / BookPrice ÷ Book value/share | 0.40x | 17.55x |
| Price / FCFMarket cap ÷ FCF | — | 285.53x |
Profitability & Efficiency
NTRA leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
NTRA delivers a -15.3% return on equity — every $100 of shareholder capital generates $-15 in annual profit, vs $-35 for QTRX. NTRA carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to QTRX's 0.13x. On the Piotroski fundamental quality scale (0–9), NTRA scores 5/9 vs QTRX's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -35.2% | -15.3% |
| ROA (TTM)Return on assets | -26.0% | -10.6% |
| ROICReturn on invested capital | -21.4% | -36.1% |
| ROCEReturn on capital employed | -24.7% | -18.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 |
| Debt / EquityFinancial leverage | 0.13x | 0.13x |
| Net DebtTotal debt minus cash | $7M | -$862M |
| Cash & Equiv.Liquid assets | $30M | $1.1B |
| Total DebtShort + long-term debt | $37M | $214M |
| Interest CoverageEBIT ÷ Interest expense | — | -25.21x |
Total Returns (Dividends Reinvested)
NTRA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NTRA five years ago would be worth $21,587 today (with dividends reinvested), compared to $490 for QTRX. Over the past 12 months, NTRA leads with a +37.3% total return vs QTRX's -48.7%. The 3-year compound annual growth rate (CAGR) favors NTRA at 60.6% vs QTRX's -45.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -57.2% | -3.9% |
| 1-Year ReturnPast 12 months | -48.7% | +37.3% |
| 3-Year ReturnCumulative with dividends | -84.1% | +314.0% |
| 5-Year ReturnCumulative with dividends | -95.1% | +115.9% |
| 10-Year ReturnCumulative with dividends | -84.3% | +2089.4% |
| CAGR (3Y)Annualised 3-year return | -45.8% | +60.6% |
Risk & Volatility
NTRA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NTRA is the less volatile stock with a 1.26 beta — it tends to amplify market swings less than QTRX's 1.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NTRA currently trades 85.7% from its 52-week high vs QTRX's 31.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.98x | 1.26x |
| 52-Week HighHighest price in past year | $8.77 | $256.36 |
| 52-Week LowLowest price in past year | $2.56 | $131.81 |
| % of 52W HighCurrent price vs 52-week peak | +31.4% | +85.7% |
| RSI (14)Momentum oscillator 0–100 | 42.3 | 57.1 |
| Avg Volume (50D)Average daily shares traded | 937K | 1.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates QTRX as "Buy" and NTRA as "Buy". Consensus price targets imply 45.5% upside for QTRX (target: $4) vs 19.4% for NTRA (target: $263).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $4.00 | $262.50 |
| # AnalystsCovering analysts | 10 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
NTRA leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). QTRX leads in 1 (Valuation Metrics).
QTRX vs NTRA: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is QTRX or NTRA a better buy right now?
For growth investors, Natera, Inc.
(NTRA) is the stronger pick with 35. 9% revenue growth year-over-year, versus 2. 6% for Quanterix Corporation (QTRX). Analysts rate Quanterix Corporation (QTRX) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — QTRX or NTRA?
Over the past 5 years, Natera, Inc.
(NTRA) delivered a total return of +115. 9%, compared to -95. 1% for Quanterix Corporation (QTRX). Over 10 years, the gap is even starker: NTRA returned +20. 9% versus QTRX's -84. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — QTRX or NTRA?
By beta (market sensitivity over 5 years), Natera, Inc.
(NTRA) is the lower-risk stock at 1. 26β versus Quanterix Corporation's 1. 98β — meaning QTRX is approximately 57% more volatile than NTRA relative to the S&P 500. On balance sheet safety, Natera, Inc. (NTRA) carries a lower debt/equity ratio of 13% versus 13% for Quanterix Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — QTRX or NTRA?
By revenue growth (latest reported year), Natera, Inc.
(NTRA) is pulling ahead at 35. 9% versus 2. 6% for Quanterix Corporation (QTRX). On earnings-per-share growth, the picture is similar: Natera, Inc. grew EPS 0. 7% year-over-year, compared to -151. 0% for Quanterix Corporation. Over a 3-year CAGR, NTRA leads at 41. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — QTRX or NTRA?
Natera, Inc.
(NTRA) is the more profitable company, earning -9. 0% net margin versus -77. 1% for Quanterix Corporation — meaning it keeps -9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NTRA leads at -13. 4% versus -62. 9% for QTRX. At the gross margin level — before operating expenses — NTRA leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — QTRX or NTRA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is QTRX or NTRA better for a retirement portfolio?
For long-horizon retirement investors, Natera, Inc.
(NTRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 26)). Quanterix Corporation (QTRX) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NTRA: +20. 9%, QTRX: -84. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between QTRX and NTRA?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: QTRX is a small-cap quality compounder stock; NTRA is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.